Ras GTPase inhibitor (Hokkaido University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameRas GTPase inhibitor (Hokkaido University)
Drug Alias NameN116Y/cancer gene therapy (Hokkaido University)Ad-CEA-N116Y (Hokkaido University)Ad-CEA-N116Y
ClassificationBiologics
Mechanisms of ActionGTPase Ras inhibitors
TargetsGTPase Ras
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHokkaido University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHokkaido University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A